RPL36AL

Across TCGA pan-cancer cohorts, RPL36AL mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated RPL36AL data layer compared with 27 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RPL36AL mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RPL36AL expression acts as an unfavorable survival marker, although some lineages such as LUAD and PDAC show a favorable association.

LUAD, HNSC, and CCRCC are the cancer types where RPL36AL mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.843	0.553	.010	14	view →
HNSC	DFS	Tertile	III,IV	0.625	0.874	.004	11	view →
CCRCC	DFS	Median	All	0.859	0.956	.030	4	view →
PDAC	DFS	Median	III,IV	0.940	0.488	.024	1	view →
LSCC	OS	Quartile	All	1.000	0.837	.023	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RPL36AL–LUAD (OS)

Open the LUAD breakdown →